Literature DB >> 17189101

Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.

Ricardo Araujo1, Cidalia Pina-Vaz, Acacio Gonçalves Rodrigues.   

Abstract

The objective of this study was to compare the antifungal susceptibility profiles of 307 environmental strains and 139 clinical isolates of Aspergillus belonging to six different species. Clinical and environmental strains with minimal inhibitory concentrations (MICs) or minimal effective concentrations >or=4microg/mL to amphotericin B (AMB), itraconazole (ITC), voriconazole and caspofungin were seldom detected. However, the susceptibility profile of environmental Aspergillus non-fumigatus strains suggests a native reduced susceptibility of Aspergillus flavus and Aspergillus terreus to AMB. A single environmental strain of Aspergillus nidulans showed high in vitro resistance (MIC>or=16 microg/mL) to ITC. Aspergillus niger showed significantly higher MIC values to ITC compared with the other Aspergillus spp. Conversely, A. fumigatus and Aspergillus glaucus showed higher susceptible profiles to the antifungals. Definition of the breakpoints for the antifungal agents remains urgent. The relationship between the susceptibility pattern and the pathogenic potential also deserves more attention, particularly with regard to non-fumigatus species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17189101     DOI: 10.1016/j.ijantimicag.2006.09.019

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  20 in total

1.  An overview about the medical use of antifungals in Portugal in the last years.

Authors:  Maria Manuel da S Azevedo; Luisa Cruz; Cidália Pina-Vaz; Acácio Gonçalves-Rodrigues
Journal:  J Public Health Policy       Date:  2016-02-11       Impact factor: 2.222

2.  Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era.

Authors:  Jesús Guinea; Sandra Recio; Teresa Peláez; Marta Torres-Narbona; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

Review 3.  Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors:  Leah E Cowen; William J Steinbach
Journal:  Eukaryot Cell       Date:  2008-03-28

4.  In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.

Authors:  Mariana S Fernández; Florencia D Rojas; María E Cattana; María de Los Ángeles Sosa; Cristina A Iovannitti; Cornelia Lass-Flörl; Gustavo E Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

Review 5.  Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.

Authors:  R Araujo; M Oliveira; A Amorim; B Sampaio-Maia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

Review 6.  Regulatory circuitry governing fungal development, drug resistance, and disease.

Authors:  Rebecca S Shapiro; Nicole Robbins; Leah E Cowen
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

7.  Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.

Authors:  Klaus Leth Mortensen; Emilia Mellado; Cornelia Lass-Flörl; Juan Luis Rodriguez-Tudela; Helle Krogh Johansen; Maiken Cavling Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

8.  Fatal brain infection caused by Aspergillus glaucus in an immunocompetent patient identified by sequencing of the ribosomal 18S-28S internal transcribed spacer.

Authors:  R S Traboulsi; M M Kattar; O Dbouni; G F Araj; S S Kanj
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

9.  Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli.

Authors:  Kizee A Etienne; Rui Kano; S Arunmozhi Balajee
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

10.  Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.

Authors:  Faten Al-Wathiqi; Suhail Ahmad; Ziauddin Khan
Journal:  BMC Infect Dis       Date:  2013-03-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.